Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cerus Corp (NQ: CERS )

1.790 +0.170 (+10.49%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,523,122
Open 1.660
Bid (Size) 1.690 (3)
Ask (Size) 1.800 (5)
Prev. Close 1.620
Today's Range 1.640 - 1.830
52wk Range 1.205 - 3.080
Shares Outstanding 180,552,190
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CERS Stock Earnings: Cerus Meets EPS, Misses Revenue for Q1 2024
CERS stock results show that Cerus met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Cerus Corporation Announces First Quarter 2024 Financial Results
From Cerus Corporation
Via Business Wire

Performance

YTD
-17.13%
-17.13%
1 Month
-4.28%
-4.28%
3 Month
-4.79%
-4.79%
6 Month
+5.29%
+5.29%
1 Year
-19.00%
-19.00%

More News

Read More
Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
From Cerus Corporation
Via Business Wire
Perion Network Cuts Sales Outlook, Joins Range Resources And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Cerus Corp. (NASDAQ: CERS) Making Surprising Moves in Wednesday Session
Via Investor Brand Network
Cerus: Q4 Earnings Insights
Via Benzinga
Cerus's Earnings: A Preview
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life
From Cerus Corporation
Via Business Wire
Cathie Wood's Ark Invest Sells Another Tranche Of Block Shares, Even As Bitcoin Price Stages A Recovery
Via Benzinga
Why Blood Components-Focused Cerus Stock Is Rising Tuesday
Via Benzinga
Exposures Product Safety
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients
From Cerus Corporation
Via Business Wire
Cathie Wood's Ark Invest Sells Coinbase Shares As Bitcoin Hits Yet Another All-Time New High, Buys Stock Of This Social Media Company
Via Benzinga
Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
CERS Stock Earnings: Cerus Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
From Cerus Corporation
Via Business Wire
Earnings Scheduled For March 5, 2024
Via Benzinga
Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024
From Cerus Corporation
Via Business Wire
GE HealthCare Technologies Posts Upbeat Earnings, Joins Toyota, Spotify And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Cerus Corporation to Participate in Upcoming Investor Conferences
From Cerus Corporation
Via Business Wire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
3 Growth Stocks That Could Go Parabolic in 2024
Via The Motley Fool
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update
From Cerus Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.